Next-generation T cell-activating vaccination increases influenza virus mutation prevalence

Sci Adv. 2022 Apr 8;8(14):eabl5209. doi: 10.1126/sciadv.abl5209. Epub 2022 Apr 6.

Abstract

To determine the potential for viral adaptation to T cell responses, we probed the full influenza virus genome by next-generation sequencing directly ex vivo from infected mice, in the context of an experimental T cell-based vaccine, an H5N1-based viral vectored vaccinia vaccine Wyeth/IL-15/5Flu, versus the current standard-of-care, seasonal inactivated influenza vaccine (IIV) and unvaccinated conditions. Wyeth/IL-15/5Flu vaccination was coincident with increased mutation incidence and frequency across the influenza genome; however, mutations were not enriched within T cell epitope regions, but high allele frequency mutations within conserved hemagglutinin stem regions and PB2 mammalian adaptive mutations arose. Depletion of CD4+ and CD8+ T cell subsets led to reduced frequency of mutants in vaccinated mice; therefore, vaccine-mediated T cell responses were important drivers of virus diversification. Our findings suggest that Wyeth/IL-15/5Flu does not generate T cell escape mutants but increases stochastic events for virus adaptation by stringent bottlenecks.

MeSH terms

  • Animals
  • Genome, Viral
  • Humans
  • Influenza A Virus, H5N1 Subtype* / genetics
  • Influenza Vaccines*
  • Influenza, Human* / prevention & control
  • Interleukin-15 / genetics
  • Mice
  • Mutation
  • Orthomyxoviridae Infections
  • Prevalence
  • Vaccination

Substances

  • Influenza Vaccines
  • Interleukin-15